Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients: The VANCS II Randomized Clinical Trial
Academic Article
Publication Date:
2019
abstract:
Previous trials suggest that vasopressin may improve outcomes in patients with vasodilatory shock. The aim of this study was to evaluate whether vasopressin could be superior to norepinephrine to improve outcomes in cancer patients with septic shock.
Iris type:
1.1 Articolo in rivista
List of contributors:
Hajjar, Ludhmila Abrahão; Zambolim, Cristiane; Belletti, Alessandro; de Almeida, Juliano Pinheiro; Gordon, Anthony C; Oliveira, Gisele; Park, Clarice Hyesuk Lee; Fukushima, Julia Tizue; Rizk, Stephanie Itala; Szeles, Tais Felix; Dos Santos Neto, Nestor Cordeiro; Filho, Roberto Kalil; Galas, Filomena Regina Barbosa Gomes; Landoni, Giovanni
Published in: